Loading
GNI Group Ltd.: what insiders have been doing
Only a handful of insider records exist for GNI Group Ltd., the last one from 6 July 2026, too few to describe a trend. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,612 of 24,148 companies
33.0
score / 100
Value27
Quality39
FCF yld-2.0%
Earn yld-2.2%
EV/EBITDA·
ROE-10%
Gross mgn74%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
JP¥2,940
Analyst consensus
2 analysts1.00/5
JP¥3,800Target JP¥4,400(+50%)JP¥5,000
Income statement
RevenueJP¥26.8B
Gross profitJP¥20B74% margin
EBITDA-JP¥1.7B-7% margin
Net income-JP¥4.2B-20.0% margin
Valuation
P/Book4.1x
Beta1.19
Balance sheet & cash
Market capJP¥193.5B
Total debtJP¥5.4B
Free Cash Flow-JP¥4B
Debt / Equity8%
Profitability & ownership
ROE-10.3%
ROA-0.7%
% insiders16.6%
% institutions9.4%
Last declaration on 6 July 2026
Declarations5 total
ShareXTKSEDINET:S100YNWS
100.0% of flowShareXTKSEDINET:S100SCVL
ShareXTKSEDINET:S100RT3E
ShareXTKSEDINET:S100RQ8T
5 of 5 declarations
About GNI Group Ltd.
GNI Group, Inc. is a company listed on the XTKS market. It is involved in the biopharmaceutical sector, focusing on the development of innovative treatments.